Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2A
Federica Rizzo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 0
Related Papers
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
|Cellular and Molecular Life Sciences|2023|20